Found: 5
Select item for more details and to access through your institution.
Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 639, doi. 10.1002/ajh.24016
- By:
- Publication type:
- Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical use of FLT3 inhibitors in acute myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 7041, doi. 10.2147/OTT.S171640
- By:
- Publication type:
- Article
Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 294, doi. 10.3816/CBC.2010.n.038
- By:
- Publication type:
- Article
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 8, p. 1963, doi. 10.1002/ijc.25843
- By:
- Publication type:
- Article